Neuroprotective activity of orexin system in ischemic stroke
نویسندگان
چکیده
منابع مشابه
Study of the Neuroprotective Effects of Memantine in Patients with Mild to Moderate Ischemic Stroke
Introduction: Ischemic stroke is amongst the top four causes of mortality and the leading cause of disability in the world. The aim of this study was to evaluate the efficacy of a high dose memantine on neurological function of patients with ischemic stroke.Methods: In a randomized, 2 armed, open-label study, patients with mild to moderate cerebral thromboembolic event (CTEE) who admitted to Im...
متن کاملStudy of the Neuroprotective Effects of Memantine in Patients with Mild to Moderate Ischemic Stroke
Introduction: Ischemic stroke is amongst the top four causes of mortality and the leading cause of disability in the world. The aim of this study was to evaluate the efficacy of a high dose memantine on neurological function of patients with ischemic stroke.Methods: In a randomized, 2 armed, open-label study, patients with mild to moderate cerebral thromboembolic event (CTEE) who admitted to Im...
متن کاملneuroprotective effects of erythropoietin in acute ischemic stroke
background: ischemic brain strokes consisttwo‑thirdsof strokesand their complications bear a lot of disability for patient and society. in this study, we seek for effect of erythropoietin on ischemic brain stroke’s outcomes according to national institutes of health stroke scale (nihss) changes. methods: this study is a rct (randomized clinical trial). all patients with focal neurologic deficit...
متن کاملNeuroprotective effects of estrogens following ischemic stroke.
Our laboratory has investigated whether and how 17beta-estradiol (E(2)) protects the brain against neurodegeneration associated with cerebrovascular stroke. We have discovered that low, physiological concentrations of E(2), which are strikingly similar to low-basal circulating levels found in cycling mice, dramatically protect the brain against stroke injury, and consequently revealed multiple ...
متن کاملDuration of neuroprotective treatment for ischemic stroke.
BACKGROUND The therapeutic time window for thrombolysis appears to be extremely short, probably because of the hemorrhagic complications associated with late reperfusion of ischemic brain tissue. Other neuroprotective forms of treatment continue to be developed, although their efficacy has yet to be conclusively proved in patients. The duration of treatment in recent phase 3 trials ranges from ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Regional blood circulation and microcirculation
سال: 2018
ISSN: 1682-6655
DOI: 10.24884/1682-6655-2018-17-2-4-11